XENTRIA: PROPOSED AMENDMENT TO XTMAB-16-201 PART B TO EVALUATE 4MG/KG EVERY FOUR WEEKS IN A 52-WEEK EFFICACY STUDY CALLED XATLAS STUDY

Reuters · 2d ago

Please log in to view news